ChemoMetec Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Martin Behrens

Chief executive officer

DKK 2.9m

Total compensation

CEO salary percentage30.0%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.4yrs

Recent management updates

Recent updates

We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

Sep 18
We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Jul 29
What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

Jul 29
Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

Jul 03
What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

Apr 15
Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

Mar 01
What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Mar 01
What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 08
Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Dec 21
Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Nov 15
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 17
ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Sep 15
A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Jun 20
At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Jun 01
With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

Jan 24
Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Oct 26
If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Oct 05
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Jul 18
Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Mar 27
Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 12
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Aug 29
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Apr 28
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 18
ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

Feb 10
ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Jan 15
What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 20
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Nov 22
ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

CEO Compensation Analysis

How has Martin Behrens's remuneration changed compared to ChemoMetec's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024DKK 3mDKK 877k

DKK 136m

Compensation vs Market: Martin's total compensation ($USD438.21K) is below average for companies of similar size in the Danish market ($USD1.77M).

Compensation vs Earnings: Insufficient data to compare Martin's compensation with company performance.


CEO

Martin Behrens (32 yo)

less than a year

Tenure

DKK 2,923,041

Compensation

Mr. Martin Helbo Behrens serves as CEO at ChemoMetec A/S since March 13, 2024. He is Chief Operating Officer of ChemoMetec A/S from December 2023. He was Vice Chief Operating Officer of ChemoMetec A/S from...


Leadership Team

NamePositionTenureCompensationOwnership
Martin Behrens
CEO & COOless than a yearDKK 2.92mno data
Hans Glensbjerg
Senior Advisorless than a yearDKK 150.00k0.27%
DKK 19.3m
Kim Nicolajsen
Chief Financial Officerless than a yearno datano data
Christopher Runchel
Chief Sales Officerno datano datano data
Marta Planaguma
Chief Marketing & Strategy Officerless than a yearno datano data
Lisbet Helles
Head of Marketingless than a yearno datano data
Søren Kjærulff
Head of R&Dno datano datano data
Bo Nielsen
Chief R&D Officer and Physicist & Project Managerless than a yearno datano data

0.8yrs

Average Tenure

44yo

Average Age

Experienced Management: CHEMM's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter Reich
Independent Director9.9yrsDKK 100.00k0.0083%
DKK 592.9k
Kristine Faerch
Independent Director3.9yrsDKK 100.00k0.00032%
DKK 22.8k
Niels Thestrup
Chairman2.9yrsDKK 360.00k0.011%
DKK 797.2k
Betina Hagerup
Independent Director2.9yrsDKK 100.00k0.0017%
DKK 119.6k

3.4yrs

Average Tenure

62yo

Average Age

Experienced Board: CHEMM's board of directors are considered experienced (3.4 years average tenure).